Tong C, Zhang Y, Liu Y, et al. Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma. Blood. 2020;136(14):1632-1644
Blood, 2023-04, Vol.141 (15), p.1896-1896
[Periódico revisado por pares]
United States: Elsevier Inc
Texto completo disponível